Related Experiment Video
Updated: May 22, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease
Chien-An A Hu1, Edward I Klopfer, Patricio E Ray
1Department of Biochemistry and Molecular Biology, University of New Mexico, Health Sciences Center, Albuquerque, NM 87131-0001, USA. AHu@salud.unm.edu
Abstract:
Human apolipoprotein L1 (ApoL1) possesses both extra- and intra-cellular functions crucial in host defense and cellular homeostatic mechanisms. Alterations in ApoL1 function due to genetic, environmental, and lifestyle factors have been associated with African sleeping sickness, atherosclerosis, lipid disorders, obesity, schizophrenia, cancer, and chronic kidney disease (CKD). Importantly, two alleles of APOL1 carrying three coding-sequence variants have been linked to CKD, particularly in Sub-Saharan Africans and African Americans. Intracellularly, elevated ApoL1 can induce autophagy and autophagy-associated cell death, which may be critical in the maintenance of cellular homeostasis in the kidney. Similarly, ApoL1 may protect kidney cells against renal cell carcinoma (RCC). We summarize the role of ApoL1 in RCC and CKD, highlighting the critical function of ApoL1 in autophagy.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Non-LTR Retrotransposons
Chronic Kidney Disease II: Clinical Manifestations
The Intrinsic Apoptotic Pathway
lncRNA - Long Non-coding RNAs
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...

